Skip to main content

People in the News: Daniel O'Day, Pascal Soriot, Roland Diggelmann

Premium

Roche has appointed Daniel O'Day, current COO of Roche Diagnostics, to be COO of Roche Pharma. O'Day replaces Pascal Soriot, who has left Roche to become CEO of AstraZeneca. Roland Diggelmann will succeed O'Day as COO of Roche Diagnostics, the company said.

Diggelmann, who currently is head of the Asia-Pacific region within Roche Diagnostics, also has been appointed to be a new member of the executive committee by the board of directors. Diggelmann joined Roche in 2008, and he formerly worked in sales and marketing in Europe and the Asia-Pacific region with Sulzer Medica/Centerpulse and Zimmer.

O'Day has held various positions at Roche since he started with Roche Pharmaceuticals in 1987, including serving as head of molecular diagnostics.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.